{"id":"W1751016438","doi":"10.1007/s00277-015-2478-9","title":"Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings","year":2015,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital","funders":"Celgene; H. Lundbeck A/S; Teva Pharmaceutical Industries","keywords":"Bendamustine; Medicine; Internal medicine; Mantle cell lymphoma; Neutropenia; Tolerability; Gastroenterology; Rituximab; Nausea; Adverse effect; Progressive disease; Salvage therapy; Phases of clinical research; Surgery; Febrile neutropenia; Lymphoma; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001429539,0.001708117,0.002436698,0.0005863192,0.0003937097,0.001043726,0.001174977,0.001184846,0.002710281],"category_scores_gemma":[0.0008461464,0.0007533747,0.001499159,0.0004895082,0.001272479,0.001072368,0.0003482666,0.003216441,0.000833724],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009872816,"about_ca_system_score_gemma":0.001251615,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001343924,"about_ca_topic_score_gemma":0.002566232,"domain_scores_codex":[0.9994351,0.0002916308,0.00002573855,0.00009546994,0.00004754512,0.000104517],"domain_scores_gemma":[0.9992548,0.0001408417,0.0001325145,0.00009274111,0.00003942365,0.0003398017],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7865293,0.06875254,0.004082398,0.000501841,0.002196432,0.0003861465,0.0002709321,0.002538774,0.08273364,0.0002321788,0.001665944,0.05010984],"study_design_scores_gemma":[0.5338035,0.4479055,0.008011079,0.00002676453,0.0007319906,0.0003608252,0.00006597239,0.001076601,0.006265004,0.0001303482,0.001588337,0.00003417136],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951963,0.001653623,0.0005131732,0.0002196623,0.00007097493,0.0006897188,0.000575338,0.00006606354,0.001015217],"genre_scores_gemma":[0.9947593,0.00109242,0.0009222682,0.0003189735,0.00013165,0.0005671903,0.001107278,0.00002774972,0.001073217],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002710281,"threshold_uncertainty_score":0.00906682,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0478569194042865,"score_gpt":0.329224975148347,"score_spread":0.2813680557440605,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}